Zoetis Inc. (ZTS)
| Market Cap | 82.11B |
| Revenue (ttm) | 7.01B |
| Net Income (ttm) | 1.77B |
| Shares Out | 475.50M |
| EPS (ttm) | 3.42 |
| PE Ratio | 50.16 |
| Forward PE | 39.06 |
| Dividend | $0.80 |
| Dividend Yield | 0.47% |
| Trading Day | May 7 |
| Last Price | $171.55 |
| Previous Close | $167.52 |
| Change ($) | 4.03 |
| Change (%) | 2.41% |
| Day's Open | 169.19 |
| Day's Range | 169.00 - 173.26 |
| Day's Volume | 1,492,644 |
| 52-Week Range | 121.00 - 176.38 |
Zoetis (ZTS) beat estimates for both earnings and revenues in the first quarter of 2021.
Zoetis (ZTS) delivered earnings and revenue surprises of 21.15% and 7.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #earnings--Zoetis reports first quarter 2021 results.
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoetis (ZTS) will report earnings and revenues, and provide pipeline updates when it releases first-quarter 2021 results.
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #earnings--Zoetis will report Q1 2021 financial results on May 6th.
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock?
USNA vs. ZTS: Which Stock Is the Better Value Option?
Zoetis has proven to investors that the pharmaceutical apple doesn't fall far from the tree.
This leader in animal healthcare has shown strong financial performance through the years.
The animal health leader continues to invest in its future.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Zoetis today announced its long-term sustainability goals.
Zoetis Inc (NYSE: ZTS) seems well-positioned in 2021 with the stock valuation offering an attractive entry point, according to BofA Securities. The Zoetis Analyst: Michael Ryskin upgraded the rating for...
USNA vs. ZTS: Which Stock Is the Better Value Option?
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #fortune500--Zoetis will participate in the Cowen 41st Annual Health Care Conference on Monday, March 1, 2021.
When it comes to stocks to buy, we are getting more selective, and that's a good thing. In fact, buying pressure in more selective stocks means they may have more profit potential going forward.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. will participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum on Thursday, Feb. 25, 2021.
Animal health company Zoetis Inc (NYSE: ZTS) received the European Commission's marketing approval for Solensia (frunevetmab), an injectable monoclonal antibody for the alleviation of pain associated wi...
ZAVENTEM, Belgium--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis receives European Commission marketing authorization for Solensia® (frunevetmab), a new therapy for feline osteoarthritis pain.
Pet adoption theme will continue, says petcare company Zoetis' CEO
Pet care company Zoetis beat on the top and bottom lines after reporting earnings this morning. The company is seeing strong momentum for 2021, despite pandemic uncertainty.
Zoetis Inc. (NYSE: ZTS) said on Tuesday that its revenue in the fiscal fourth quarter saw an 8% annualised growth to £1.29 billion. Its net income in Q4 stood at £258.21 million that translates to 53.94...
Zoetis (ZTS) beats both earnings and sales estimates in the fourth quarter of 2020.
Zoetis earnings and sales were better than expected, while the animal drug giant guided high for 2021. ZTS stock rose early Tuesday.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis reports fourth quarter and full year 2020 financial results.
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zoetis (ZTS) will report earnings and revenues, and provide other pipeline updates when it releases fourth-quarter 2020 results.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #dividend--Zoetis declares Q2'21 dividend.
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Forbes--Zoetis has been named one of America's Best Midsize Employers by Forbes Magazine for the fifth time.
GRFS vs. ZTS: Which Stock Is the Better Value Option?
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #LGBTQ--Zoetis named a best place to work for LGBTQ equality.
These are some of the top stocks to buy if you want to make a play on the growth and strength of the Chinese economy. The post 9 Hot Stocks to Buy Now to Profit off Chinese Markets appeared first on Inv...
Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 2021. But fi...
Both stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average and median increase of 15.13%.
Families are adopting, spending more on pets amid pandemic: Zoetis CEO
Shelters have seen pet adoptions increase 15% year over year. As Americans spend more time at home with their companions, it has led to more spending on pet care, animal pharmaceuticals provider Zoetis ...
Homebound families are spending more time and money on pets, Zoetis CEO Kristin Peck told CNBC's Jim Cramer on Wednesday.
Rising pet ownership rates and a steadily increasing average household spending provide a powerful tailwind to this investment theme. Pet food, animal health, veterinary equipment, and specialized e-com...
GRFS vs. ZTS: Which Stock Is the Better Value Option?
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader
This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfolio manager...
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis will report Q4 and full year 2020 financial results on Tuesday, Feb 16, 2021.
Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on InvestorP...
These biotech stocks allow you to profit off the innovations that are giving us longer, healthier lives through the companies that make them. The post 5 Rational Biotech Stocks to Buy appeared first on ...
About ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Feb 1, 2013 |
| CEO Kristin Peck | Employees 11,300 |
| Stock Exchange NYSE | Ticker Symbol ZTS |
Financial Performance
In 2020, Zoetis's revenue was $6.68 billion, an increase of 6.63% compared to the previous year's $6.26 billion. Earnings were $1.64 billion, an increase of 9.20%.
Analyst Forecasts
According to 21 analysts, the average rating for Zoetis stock is "Buy." The 12-month stock price forecast is 189.47, which is an increase of 10.45% from the latest price.